News & Events
More Du Pré Grants for 2014 announced
The second wave of 2014 grants includes scientists from Iran, Italy, Romania and Russia
New type of interferon has fewer side effects
Pegylated interferon lasts longer, so needs to be taken less often, with fewer side effects
Pros and cons of alemtuzumab
Alemtuzumab has been approved in Europe, Canada, Australia, and Latin America
Better test for risk of PML infection in Natalizumab patients
The new test measures the risk of PML infection in people being treated with Natalizumab
New markers to stop inflammation in multiple sclerosis
An imbalance in the production of two molecules may play a role in MS inflammation
A diet with high salt intake can worsen MS course
Researchers found correlations between increased number of lesions in patients' brains and their level of salt intake
MS International Federation launches new website
The site includes a members' area and more content in Arabic and Spanish
MS Society of India raises awareness in Surat
The Mumbai Chapter organised a programme of talks in Surat, Gujarat
Swedish government to develop national guidelines
Neuroförbundets will take part in the national and regional hearings
Alliance announces first round of grants
The Progressive MS Alliance has awarded its first round of 22 research grants to investigators in nine…
Amalia wins Evelyn Nicholson Award
Amalia cared for her husband, Ernesto Sepúlveda Morales, who had MS, throughout 40 years of marriage
MS International Federation announces first wave of 2014 Du Pré Grants
The MS International Federation has announced its first six Du Pré Grants for 2014